Cargando…
Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer
BACKGROUND: Delivery of a high concentration of anticancer drugs specifically to cancer cells remains the biggest challenge for the treatment of multidrug-resistant cancer. Poloxamers and D-α-Tocopheryl polyethylene glycol 1000 succinate (TPGS) are known inhibitors of P-glycoprotein (P-gp). Mixed mi...
Autores principales: | Saxena, Vipin, Hussain, M Delwar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284221/ https://www.ncbi.nlm.nih.gov/pubmed/22359450 http://dx.doi.org/10.2147/IJN.S28745 |
Ejemplares similares
-
Synergistic effect of pH-responsive folate-functionalized poloxamer 407-TPGS-mixed micelles on targeted delivery of anticancer drugs
por: Butt, Adeel Masood, et al.
Publicado: (2015) -
TPGS/Phospholipids Mixed Micelles for Delivery of Icariside II to Multidrug-Resistant Breast Cancer
por: Song, Jie, et al.
Publicado: (2015) -
Micellar systems of poloxamer 407 and 403 for quercetin delivery
por: Araujo, Juscemácia, et al.
Publicado: (2014) -
Thermogelling properties of purified poloxamer 407
por: Fakhari, Amir, et al.
Publicado: (2017) -
Enhanced Tumor Delivery of Gemcitabine via PEG-DSPE/TPGS
Mixed Micelles
por: Wang, Yingzhe, et al.
Publicado: (2014)